OBJECTIVE: The anatomic and physiologic constraints for pediatric cavopulmonary assist differ markedly from adult Fontan circulations owing to smaller vessel sizes and risk of elevated pulmonary resistance. In this study, hemodynamic and hemolysis performance of a catheter-based viscous impeller pump (VIP) to power the Fontan circulation is assessed at a pediatric scale (∼15 kg) and performance range (0-30 mm Hg). METHODS: Computer simulation and mock circulation studies were conducted to assess the hydraulic performance, acute hemodynamic response to different levels VIP support, and the potential for vena caval collapse. Computational fluid dynamics simulations were used to estimate VIP hydraulic performance, shear rates, and potential for hemolysis. Hemolysis was quantified in a mock loop with fresh bovine blood. RESULTS: A VIP augmented 4-way total cavopulmonary connection flow at pediatric scales and restored systemic pressures and flows to biventricular values, without causing flow obstruction or suction. VIP generated flows up to 4.1 L/min and pressure heads of up to 38 mm Hg at 11,000 rpm. Maximal shear rate was 160 Pa, predicting low hemolysis risk. Observed hemolysis was low with plasma free hemoglobin of 11.4 mg · dL(-1) · h(-1). CONCLUSIONS: A VIP will augment Fontan cavopulmonary flow in the proper pressure and flow ranges, with low hemolysis risk under more stringent pediatric scale and physiology compared with adult scale. This technology may be developed to simultaneously reduce systemic venous pressure and improve cardiac output after stage 2 or 3 Fontan repair. It may serve to compress surgical staging, lessening the pathophysiologic burden of repair.
OBJECTIVE: The anatomic and physiologic constraints for pediatric cavopulmonary assist differ markedly from adult Fontan circulations owing to smaller vessel sizes and risk of elevated pulmonary resistance. In this study, hemodynamic and hemolysis performance of a catheter-based viscous impeller pump (VIP) to power the Fontan circulation is assessed at a pediatric scale (∼15 kg) and performance range (0-30 mm Hg). METHODS: Computer simulation and mock circulation studies were conducted to assess the hydraulic performance, acute hemodynamic response to different levels VIP support, and the potential for vena caval collapse. Computational fluid dynamics simulations were used to estimate VIP hydraulic performance, shear rates, and potential for hemolysis. Hemolysis was quantified in a mock loop with fresh bovine blood. RESULTS: A VIP augmented 4-way total cavopulmonary connection flow at pediatric scales and restored systemic pressures and flows to biventricular values, without causing flow obstruction or suction. VIP generated flows up to 4.1 L/min and pressure heads of up to 38 mm Hg at 11,000 rpm. Maximal shear rate was 160 Pa, predicting low hemolysis risk. Observed hemolysis was low with plasma free hemoglobin of 11.4 mg · dL(-1) · h(-1). CONCLUSIONS: A VIP will augment Fontan cavopulmonary flow in the proper pressure and flow ranges, with low hemolysis risk under more stringent pediatric scale and physiology compared with adult scale. This technology may be developed to simultaneously reduce systemic venous pressure and improve cardiac output after stage 2 or 3 Fontan repair. It may serve to compress surgical staging, lessening the pathophysiologic burden of repair.
Authors: L Macé; P Dervanian; A Bourriez; G M Mazmanian; V Lambert; J Losay; J Y Neveux Journal: Am J Physiol Heart Circ Physiol Date: 2000-11 Impact factor: 4.733
Authors: Mark D Rodefeld; Jack H Boyd; Cynthia D Myers; Brian J LaLone; Alex J Bezruczko; Andrew W Potter; John W Brown Journal: Ann Thorac Surg Date: 2003-12 Impact factor: 4.330
Authors: George M Pantalos; Steven C Koenig; Kevin J Gillars; Guruprasad A Giridharan; Dan L Ewert Journal: ASAIO J Date: 2004 Jan-Feb Impact factor: 2.872
Authors: Mark D Rodefeld; Jack H Boyd; Cynthia D Myers; Robert G Presson; Wiltz W Wagner; John W Brown Journal: J Thorac Cardiovasc Surg Date: 2004-03 Impact factor: 5.209
Authors: Guruprasad A Giridharan; Michael A Sobieski; Mickey Ising; Mark S Slaughter; Steven C Koenig Journal: Biomed Instrum Technol Date: 2011 Jul-Aug
Authors: David A Ashburn; Brian W McCrindle; Christo I Tchervenkov; Marshall L Jacobs; Gary K Lofland; Edward L Bove; Thomas L Spray; William G Williams; Eugene H Blackstone Journal: J Thorac Cardiovasc Surg Date: 2003-05 Impact factor: 5.209
Authors: Steven C Koenig; Cary Woolard; Guy Drew; Lauren Unger; Kevin Gillars; Dan Ewert; Laman Gray; George Pantalos Journal: Biomed Instrum Technol Date: 2004 May-Jun
Authors: Guruprasad A Giridharan; Mickey Ising; Michael A Sobieski; Steven C Koenig; Jun Chen; Steven Frankel; Mark D Rodefeld Journal: ASAIO J Date: 2014 Nov-Dec Impact factor: 2.872
Authors: Andrew L Cheng; Niema M Pahlevan; Derek G Rinderknecht; John C Wood; Morteza Gharib Journal: Eur J Mech B Fluids Date: 2017-12-27 Impact factor: 2.183
Authors: Michael Tree; Zhenglun Alan Wei; Phillip M Trusty; Vrishank Raghav; Mark Fogel; Kevin Maher; Ajit Yoganathan Journal: Ann Biomed Eng Date: 2017-10-24 Impact factor: 3.934